论文部分内容阅读
王毓銮(山西省肿瘤医院) 近年来,由于采用联合化疗、支持疗法,以及骨髓移植的开展,使急性白血病的生存期显著延长。现在,儿童急性淋巴细胞白血病(急淋)的完全缓解率已达90％,有50％可长期存活。急性非淋巴细胞白血病(急非淋)的治疗,也有很大进展。近几年,大剂量阿糖胞苷和氨甲喋呤对难治或复发的急非淋,取得了较好疗效。以三尖杉酯碱为主治疗急非淋,也获得显
Wang Yiluan (Shanxi Cancer Hospital) In recent years, due to the use of combination chemotherapy, supportive therapy, and bone marrow transplantation, the survival of acute leukemia significantly prolonged. Now, the complete remission rate of childhood acute lymphoblastic leukemia (acute lymphoblastic) has reached 90%, 50% of long-term survival. Acute non-lymphocytic leukemia (acute fecal non-leaching) treatment, but also great progress. In recent years, high doses of cytarabine and methotrexate refractory or relapse of the emergency non-Lin, and achieved good results. Harringtonine-based treatment of acute Fei Lin, also obtained significant